Thanks for Reaching Out!

We'll be in touch to follow up.

Additional State Licensing Insights

What manufacturers need to know about Minnesota House Bill 400

We recently notified our clients and partners of several regulatory changes that will affect manufacturers and wholesalers doing business in Minnesota. In May 2019, Minnesota Governor Tim Walz signed House Bill 400, which created an Opioid Stewardship Advisory Council to confront the opioid addiction crisis and overdose epidemic.

Learn More >

New regulation requirements impacting your license

In the pharmaceutical industry, state licensing requirements can change at a moment’s notice. Though no central “hub” exists listing all licensing updates for each state, our team of experts works with state boards on a routine basis to track all license requirement updates.

Learn More >

We’re here to support your success from clinical to commercial – and beyond.

How can we help you today?